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ABSTRACT 
BACKGROUND: Oral vaccination with live-attenuated S. Typhi (Ty21a) is modestly 
efficacious, however the mechanisms of protection are currently unknown. While humoral 
and cellular immune responses are well-described in peripheral blood, the cellular response at 
the intestinal mucosa has never been directly assessed. 
METHODS: We vaccinated healthy adults with Ty21a and assessed humoral and cellular 
immunity in vaccinated volunteers and controls after 18 days. Immunoglobulin levels were 
assessed in peripheral blood by enzyme-linked immunosorbent assay. Cellular responses 
were assessed in peripheral blood and at the duodenal and colonic mucosa by flow cytometry. 
RESULTS: We demonstrate the generation of Ty21a-responsive and heterologous influenza-
responsive CD4+ and CD8+ T-cells at the duodenal mucosa. All duodenal responses were 
consistently correlated and no responses were observed at the colonic mucosa. Peripheral 
anti-lippopolysaccharide IgG and IgA responses were significantly correlated with duodenal 
responses. The assessment of integrin β7 expression intensity among peripheral and duodenal 
T-cell subsets revealed varied capacities for mucosal homing and residence.  
CONCLUSIONS: The breadth of duodenal cellular responses was not reflected peripherally. 
The direct evaluation of mucosal immune defence may yield functional correlates of 
protection, and could provide insight into mechanisms which may be manipulated in order to 
enhance vaccine immunogenicity.  
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INTRODUCTION 
Salmonella enterica serovar Typhi (S. Typhi) is a human host-restricted, intracellular 
pathogen, and the causative agent of typhoid fever. Following ingestion, the bacteria cause 
systemic illness following invasion via the mucosal surface of the small intestine.[1] In the 
1970s, through chemical mutagenesis of pathogenic S. Typhi strain Ty2, a live-attenuated 
oral typhoid vaccine was developed – Ty21a.[2] Vaccination with three doses of Ty21a is 
moderately protective and, although estimates of efficacy vary,[3-5] a recently published 
review calculated a cumulative efficacy of 48% three years following vaccination.[6]  
Ty21a is able to induce humoral and cellular immune responses, both of which have been 
implicated in protection against disease. While opsonophagocytic antibody function,[7] 
cellular cytotoxicity, proliferation, and cytokine production functionality have been assessed 
in peripheral blood following vaccination with Ty21a,[8-13] cellular immunity at the human 
intestinal mucosa has never been directly assessed. Numerous studies have demonstrated that 
cellular immune responses generated through vaccination with Ty21a are primed for mucosal 
homing,[13-15] highlighting the importance of mucosal immunity in defence against disease. 
Furthermore, it has been demonstrated that the assessment of vaccine immunogenicity by 
peripheral sampling alone provides an incomplete reflection of vaccine immunogenicity.[16]  
It has previously been observed in murine models that previously primed T-cells of 
heterologous specificities are recruited to the lung during influenza infection.[17] Although 
this phenomenon has not been observed in humans, we hypothesised that vaccination with 
Ty21a could enhance T-cell responses to heterologous antigens at the mucosal surface by a 
similar mechanism.  
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Through the direct assessment of immunity at the intestinal mucosa, it may be possible to 
identify mechanisms involved in the induction of protective immunity, which may be 
manipulated in order to improve oral vaccine immunogenicity. Here, we have assessed 
cellular immunity in vaccinated volunteers and controls at the duodenal and colonic mucosa 
and in peripheral blood after 18 days. We have compared and correlated peripheral and 
mucosal cellular responses with accepted peripheral humoral measures of vaccine efficacy, 
providing a unique insight into the relationship between human mucosal and peripheral 
immune defence.  
 
RESULTS 
Serum immunoglobulin specificity 
Ty21a-mediated protection is dependent upon the expression of lipopolysaccharide (LPS)[2] 
and, in field trials, humoral responses to LPS were shown to correlate with vaccine 
efficacy.[18] We compared levels of serum anti-LPS IgG and IgA prior to and following 
vaccination. We also measured levels of serum IgG and IgA specific to influenza – a 
common naturally-encountered pathogen – in order to assess the impact of vaccination on 
humoral immunity to a heterologous pathogen. Influenza was selected since the majority, if 
not all, volunteers would have been exposed to this pathogen in the community. 
While levels of anti-LPS serum IgG and IgA among unvaccinated subjects were not different 
between day 18 and day 0, levels among the vaccinated were higher at day 18 than at day 0 
(Figure 1A; P=0.03 and P=0.01). Levels of anti-influenza serum IgG or IgA among the 
unvaccinated and the vaccinated were not different between day 18 and day 0 (Figure 1B).  
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Peripheral blood and gut mucosal cellular responses 
We compared the frequency of Ty21a-responsive T-cells in vaccinated volunteers and 
controls, at the duodenal and colonic mucosa and in peripheral blood. We also measured the 
frequency of influenza-responsive T-cells.  
A combinatorial gating strategy was used to identify the proportion of CD4+ and CD8+ T-
cells positive for any combination of IFNγ ± TNFα ± IL2 (Figure 2). Cytokine production in 
non-stimulated samples (negative control) was minimal, not different between the vaccinated 
and the unvaccinated, and was subsequently subtracted from other conditions. Cytokine 
production in Staphylococcal enterotoxin B (SEB)-stimulated samples (positive control) was 
high, and was not different in the vaccinated compared to the unvaccinated. 
At day 0, in peripheral blood, the frequency of Ty21a-responsive and heterologous influenza-
responsive CD4+ and CD8+ T-cells in the vaccinated group was not different from the 
unvaccinated control group (Figure S1). These data suggest that groups were well-matched 
for prior exposure to Ty21a and influenza antigens, and that any differences observed 
thereafter may be attributed to an effect of vaccination with Ty21a. Paired comparisons 
between day 0 and day 18 were not made in peripheral blood, as overnight fasting, required 
prior to endoscopy, is known to influence cytokine production in response to restimulation 
with bacterial and viral antigens.[19] 
At day 18, at the duodenal mucosa, the frequency of Ty21a-responsive CD4+ T-cells was 
three-fold higher, and the frequency of Ty21a-responsive CD8+ T-cells five-fold higher in 
vaccinated compared to unvaccinated volunteers (Figure 3A; P=0.007 and P=<0.0001). The 
frequency of heterologous influenza-responsive CD4+ T-cells was five-fold higher, and the 
frequency of heterologous influenza-responsive CD8+ T-cells six-fold higher in vaccinated 
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compared to unvaccinated volunteers (Figure 3A; P=0.005 and P=0.01). At the colonic 
mucosa, there was no significant difference between the frequencies of Ty21a-responsive or 
heterologous influenza-responsive T-cells in vaccinated compared to unvaccinated volunteers 
(Figure 3B).  
In peripheral blood, the frequency of Ty21a-responsive CD4+ T-cells was four-fold higher in  
vaccinated compared to unvaccinated volunteers (Figure 3C; P=0.019). Vaccination did not 
influence the frequency of peripheral Ty21a-responsive CD8+ T-cells, nor the frequency of 
heterologous influenza-responsive CD4+ or CD8+ T-cells at day 18.  
Characteristics and functionality of cellular responses 
Polyfunctional T-cells – those which express multiple cytokines simultaneously – have been 
shown to correlate with vaccine mediated protection against other intracellular infections.[20, 
21] We compared the cytokine expression profile of vaccinated volunteers with that of 
unvaccinated volunteers to assess the functionality of responses to Ty21a and influenza 
antigens. 
At the duodenal mucosa, the CD4+ T-cell response to Ty21a was functionally heterogeneous, 
with the frequency of cells expressing one, two or three cytokines being higher in vaccinated 
compared to  unvaccinated volunteers (Figure 4A; P=0.006, P=0.018 and P=0.031). The 
duodenal CD8+ T-cell r sponse to Ty21a antigens was, in contrast, largely attributable to cells 
expressing just one cytokine (Figure 4A; P=0.0004). Duodenal CD4+ and CD8+ T-cell 
responses to influenza antigens were also functionally heterogeneous, with the frequency of 
cells expressing one, two or three cytokines being higher in vaccinated compared to 
unvaccinated volunteers (Figure 4B; CD4+ P=0.008, P=0.005 and P=0.005, respectively; 
CD8+ P=0.0008, P=0.010 and P=0.011). In peripheral blood, the CD4+ T-cell response to 
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Ty21a antigens was functionally heterogeneous, with the frequency of cells expressing one, 
two or three cytokines being higher in vaccinated compared to unvaccinated volunteers 
(Figure 4C; P=0.026, P=0.028 and P=0.008,). Analysis of expression profiles by individual 
cytokine demonstrated that responses to Ty21a and influenza antigens were attributable to 
cells producing combinations of IFNγ, TNFα and IL2, but that no one cytokine predominated 
(Figure S2). 
Correlations between cellular populations at the duodenal mucosa 
We explored the relationship between the generation of Ty21a-responsive and heterologous 
influenza-responsive T-cells at the duodenal mucosa. 
The frequencies of Ty21a-responsive CD4+ and CD8+ T-cells were correlated (Table 1; 
r2=0.537, P=0.015), as were the frequencies of heterologous influenza-responsive CD4+ and 
CD8+ T-cells (Table 1; r2=0.930, P=<0.0001). The frequencies of Ty21a-responsive CD4+ 
and CD8+ T-cells also correlated robustly with the frequencies of corresponding influenza-
responsive T-cells (Table 1; CD4+ r2=0.74, P=0.0003 and CD8+ r2=0.677, P=0.001).  
Correlations between peripheral and mucosal immunity 
We explored the relationship between the generation of peripheral and duodenal immune 
responses.  
The frequency of peripheral Ty21a-responsive CD4+ T-cells was modestly correlated with the 
frequency of duodenal Ty21a-responsive CD4+ T-cells (Table 1; r2=0.530, P=0.024), but not 
with the frequency of duodenal Ty21a-responsive CD8+ T-cells nor with the frequency of 
heterologous influenza-responsive CD4+ and CD8+ T-cells. 
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Levels of serum anti-LPS IgG and IgA correlated with the frequency of duodenal Ty21a-
responsive CD4+ T-cells (Table 1; IgG r2=0.542, P=0.014 and IgA r2=0.710, P=0.0004). 
Levels of serum IgA specific to LPS also correlated with the frequency of duodenal 
heterologous influenza-responsive CD4+ and CD8+ T-cells (Table 1; CD4+ r2=0.512, P=0.025 
and CD8+ r2=0.585, P=0.008). Levels of anti-influenza IgG and IgA did not, however, 
correlate with either the frequency of Ty21a-responsive or heterologous influenza-responsive 
T-cells at the duodenal mucosa in either subset.  
Cellular potential for mucosal homing and residence  
Integrin β7 plays a prominent role in mucosal cellular immune defence; α4β7 facilitates 
peripheral trafficking to the intestinal mucosa and αεβ7 helps maintain resident intraepithelial 
lymphocyte (IEL) populations.[22, 23] Since duodenal CD4+ and CD8+ T-cell responses to 
Ty21a and influenza antigens were closely correlated, we assessed the cellular capacity for 
mucosal homing and residence, this being a potential mechanism by which Ty21a 
vaccination may have influenced trafficking to the duodenal mucosa. We assessed integrin β7 
expression intensity, a component of both α4β7 in peripheral blood and αεβ7 at the duodenal 
mucosa. A combinatorial gating strategy was used to determine the level of integrin β7 
expression among CD4+ and CD8+ T-cell populations (Figure 2).  
At the duodenal mucosa, integrin β7 expression was more intense among the total CD4+ T-
cell population than among the total CD8+ T-cell population (Figure 5A; P=<0.0001). 
Integrin β7 expression intensity among Ty21a-responsive and influenza-responsive CD4+ T-
cell subpopulations was not different to that among the total mucosal CD4+ T-cell population. 
In contrast, integrin β7 expression intensity among Ty21a-responsive and influenza-
responsive CD8+ T-cell subpopulations was greater than that among the total mucosal CD8+ 
T-cell population (Figure 5A; P=0.0002 and P=<0.0001).  
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In contrast with observations made at the duodenal mucosa, integrin β7 expression was more 
intense among the total CD8+ T-cell population than among the total CD4+ T-cell population 
in peripheral blood (Figure 5B; P=0.0005). While integrin β7 expression intensity among 
Ty21a-responsive CD4+ T-cell subpopulation was greater than that among the total CD4+ T-
cell population (Figure 5B; P=0.002), expression intensity among influenza-responsive CD4+ 
T-cell subpopulation was not different to that among the total CD4+ T-cell population. 
Integrin β7 expression intensity among Ty21a-responsive and heterologous influenza-
responsive CD8+ T-cell subpopulations was greater than that among the total CD8+ T-cell 
population (Figure 5B; P=0.004 and P=0.041).  
 
DISCUSSION 
We have described, for the first time, the cellular response to oral vaccination at the human 
intestinal mucosa. We demonstrate that Ty21a vaccination generates both polyfunctional 
Ty21a-responsive and heterologous influenza-responsive T-cells at the duodenal mucosa. The 
frequency of Ty21a-responsive and influenza-responsive T-cells at the duodenal mucosa 
were robustly and consistently correlated. In contrast, cellular and humoral measurements 
made in peripheral blood were poorly correlated with one another, and did not provide insight 
into the induction of heterologous responses at the duodenal mucosa. 
While robust Ty21a and heterologous-influenza CD4+ and CD8+ T-cell responses were 
observed at the duodenal mucosa, no cellular response was observed at the colonic mucosa to 
either antigen in either T-cell subset. This suggests that duodenal responses were 
compartmentalised to the embryological mid-gut, which includes the terminal ileum – the 
likely site of active invasion by Ty21a.[1] Interestingly, the frequency of Ty21a-responsive 
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CD4+ and CD8+ T-cells correlated robustly with one another and with the frequency of 
heterologous influenza-responsive CD4+ and CD8+ T-cells at the duodenal mucosa. This 
suggests that the mechanisms responsible for the generation of these mucosal responses were 
localised and capable of influencing T-cells of different phenotypes and specificities.  
Polyfunctionality among Ty21a-responsive T-cells at the duodenal mucosa and in peripheral 
blood may point towards an important mechanism through which Ty21a confers protection 
against disease.[20, 21] Further, the generation of anti-LPS immunoglobulin, an accepted 
indication of vaccine efficacy, was closely associated with cellular responses at the duodenal 
mucosa, suggesting that mucosal cellular activity may be associated with the generation of 
protective immunity. 
In murine models, influenza infection results in the recruitment of previously-primed 
heterologous T-cells to the lung.[17] We propose that a similar mechanism was responsible 
for the generation of heterologous responses at the duodenal mucosa. Although only two 
individuals had previously been vaccinated against influenza all were likely to have been 
exposed to this mucosal pathogen in the community – indeed, at baseline, anti-influenza IgG 
and IgA, as well as influenza responsive CD4+ T-cells were detected in all volunteers, not 
just those who had been previously vaccinated against influenza.  
Trafficking to the mucosa is largely dependent upon the expression of α4β7 and its ligand 
mucosal addressin cell adhesion molecule-1 (MAdCAM-1), as well as C-C chemokine 
receptor (CCR)9 and its ligand, chemotaxis chemokine ligand (CCL)25.[24] We hypothesise 
that vaccination with Ty21a upregulated the expression of mucosal homing ligands resulting 
in the non-specific migration of previously-primed heterologous influenza-responsive T-cells, 
carrying mucosal homing receptors, to the duodenal mucosa. This effect may or may not be 
restricted to influenza responsive T-cell subsets, and further study is warranted. 
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We observed that integrin β7 expression intensity was generally higher among both Ty21a-
responsive and influenza-responsive cells, compared to total cell populations, in peripheral 
blood and at the intestinal mucosa. Multiphasic peripheral CD8+ T-cell responses have 
previously been described and attributed to the trafficking of immune cells from peripheral 
blood to the mucosa.[8, 9] In keeping with this, integrin β7 expression among peripheral 
CD8+ T-cells, particularly antigen-specific subpopulations, was more intense than that among 
peripheral CD4+ T-cells. Integrin β7 expression among CD4+ T-cell subsets was highly 
polarised, being relatively low among peripheral subsets and high among duodenal subsets. 
Differential integrin β7 expression among antigen-specific CD4+ T-cell populations may 
ensure that some peripheral T-cells persist in blood and avoid sequestration. We and others 
have demonstrated the presence of intracellular intravascular and bone-marrow bacteria in 
early, late and recurrent invasive Salmonella disease.[25, 26] Thus, while T-cells trafficking 
to the mucosa likely play a key role in the early response to invasion, CD4+ T-cell 
populations which persist in peripheral blood may help to prevent intravascular dissemination 
and persistence at secondary systemic sites of infection.  
Prior to vaccination, all volunteers had detectable baseline levels of serum immunoglobulin 
specific to S. Typhi LPS. This is likely the result of antibody binding to the core, or as a result 
of environmental exposure to non-typhoidal strains bearing the same LPS O-antigens as S. 
Typhi (O-9 and O-12); S. Enteritidis expresses both O-9 and O-12 antigens and S. 
Typhimurium expresses the O-12 antigen.[27] Not all vaccinated volunteers generated 
peripheral humoral anti-LPS responses; likely a reflection of the limited efficacy of this 
vaccine. It was interesting that mucosal cellular responses correlated strongly with serum 
anti-LPS immunoglobulin responses, as humoral responses to LPS are associated with 
vaccine efficacy.[18] This suggests that in individuals in whom Ty21a vaccination is not 
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efficacious, the failure encompasses both cellular and humoral mechanisms of defence. It has 
previously been demonstrated that the generation of immunoglobulin following oral 
vaccination is dependent upon α4β7.[28] Thus, the close association between cellular and 
humoral immune responses suggests that the strength of each volunteer’s cellular and 
humoral response to vaccination was influenced by a mucosal mechanism, possibly the 
expression intensity of α4β7 and/or MAdCAM-1 at the time of vaccination.  
It is possible that through toll-like receptor (TLR) engagement, vaccination may have non-
specifically activated mucosal antigen-presenting cells (APCs) and T-cells, resulting in 
enhanced cytokine production following experimental restimulation.[29, 30] However, as 
background cytokine production in the negative control was minimal, and as cytokine 
production in the positive control was not different in the vaccinated compared to the 
unvaccinated, we believe this is unlikely to be the primary factor responsible for the observed 
heterologous cellular response. Due to the invasive nature of endoscopic biopsy, we were 
limited to sampling from intestinal sites at a single time point. Data presented here, and 
elsewhere,[8] indicate that the assessment of mucosal immunity at alternate time points could 
provide further insight into the generation of protective immune responses. We assessed the 
expression of just three cytokines and, as a result, the T-cell populations identified here are 
unlikely to represent the responsive populations in their entirety.  
In future studies, we plan to study the effect of oral vaccination with Ty21a on the cellular 
response to a range of heterologous antigens. We will comprehensively assess cellular 
phenotype and functionality through the inclusion of additional surface markers and a broader 
repertoire of cytokines/chemokines. We also plan to further investigate the timing and 
longevity of peripheral and mucosal immune responses. 
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Taken together, our data demonstrate that oral vaccination with Ty21a generates Ty21a-
responsive T-cells as well as heterologous influenza-responsive T-cells at the duodenal 
mucosa. We propose that heterologous influenza-responsive T-cells, previously primed 
through natural exposure, were recruited to the duodenal mucosa through compartmentalised 
upregulation of homing ligands. The direct evaluation of mucosal cellular immune defence 
provides the opportunity to identify functional correlates of protection, and may offer new 
insights into mechanisms which may be manipulated to improve oral vaccine 
immunogenicity, either through the development of oral adjuvants, or the development of 
multivalent Salmonella-based vectors. 
 
MATERIALS AND METHODS 
Ethical approval, recruitment and study protocol 
All volunteers provided written informed consent. This study was approved by the UK 
National Research Ethics Service (10/H1005/20). Twenty-three healthy adult volunteers were 
enrolled into the study. Eleven volunteers (6 males and 5 females (2 previously vaccinated 
against influenza); median age 24 years) were randomly selected for oral vaccination with 
live-attenuated S. Typhi (Ty21a , Vivotif®). A single oral capsule was taken on days 0, 2 and 
4, approximately one hour before a meal, with a cold or lukewarm drink. Twelve volunteers 
(3 males and 9 females (3 previously vaccinated against influenza); median age 23 years) 
were randomly assigned to an unvaccinated control group. 
Mucosal mononuclear cell (MMC) isolation 
Mucosal samples were acquired at day 18. Nasal O2 was administered and saturation 
monitored throughout. Sedation was offered to all volunteers; those who requested sedation 
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were given up to 5mg midazolam intravenously. Using large capacity forceps (Boston 
Scientific), 12-15 single-bite mucosal biopsies were acquired during flexible video-
endoscopy, from the duodenal mucosa at D2-D3 (n=20) and from the sigmoid colon at 20-
25cm insertion (n=17). MMCs were isolated from biopsies using a modified version of a 
previously described method.[31] Full details are presented in Supplementary Materials and 
Methods. 
Peripheral blood mononuclear cell (PBMC) isolation 
Peripheral blood samples were collected in sodium heparin Vacutainers™ (BD Biosciences) 
at day 0 (n=23) and, after overnight fasting, at day 18 (n=21). PBMCs were isolated using 
Lymphoprep™ (Axis-Shield), according to the manufacturers instructions. Full details are 
presented in Supplementary Materials and Methods. 
Antigenic stimulation and incubation 
PBMCs (1 × 106 cells/mL) and MMCs (no less than 5 × 106 cells/mL) were seeded in 
complete medium in 96 well flat-bottom plates. Cells were stimulated with either 5 × 106 
colony forming units (cfu)/mL heat-killed (suspended in Dulbecco’s PBS, quantified using 
Miles and Misra technique, and incubated at 95˚C for 30 minutes) Salmonella Typhi Ty21a 
(Vivotif®), or 0.5ng/mL influenza haemagglutinin and neuraminidase antigens (Influvac® 
containing, in equal quantities, a A/Brisbane/59/2007 H1N1-like strain, a A/Brisbane/10/2007 
H3N2-like strain, and a B/Brisbane/60/2008-like strain). One positive control well was 
stimulated with 500ng/mL staphylococcal enterotoxin B (SEB) (Sigma-Aldrich). One 
negative control well was left untreated to adjust for non-antigen-specific background 
cytokine production. Cells were then incubated at 37°C in 5% CO2. After two hours, 5µL/mL 
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brefeldin A (BD GolgiPlug™; BD Biosciences) was added to each well, and the plate 
incubated for a further 16 hours at 37°C in 5% CO2. 
Flow cytometric analyses 
Following incubation, PBMCs and MMCs were washed, stained for viability, surface 
phenotype and, following fixation and permeabilisation, stained for intracellular cytokine 
production. Details of the antibodies which were used are presented in Supplementary 
Materials and Methods. Cells were washed, resuspended and stored in the absence of light at 
4°C until data were acquired using a LSR II flow cytometer (BD Biosciences). Compensation 
beads (BD Biosciences) were used to create compensation matrices and sequential cell 
isolation used to identify populations of interest (Figure 2). Full details are presented in 
Supplementary Materials and Methods. 
Enzyme-linked immunosorbent assay (ELISA) 
Each well of Maxisorp® flat-bottom 96 well plate (Nunc) was coated with 100µL carbonate-
bicarbonate buffer containing either 5µg/mL S. typhi lipopolysaccharide (Sigma-Aldrich) or 
10ng/mL influenza haemagglutinin and neuraminidase antigens (Influvac® containing, in 
equal quantities, a A/Brisbane/59/2007 H1N1-like strain, a A/Brisbane/10/2007 H3N2-like 
strain, and a B/Brisbane/60/2008-like strain) and incubated at 4°C overnight. Plates were 
washed three times with phosphate buffered saline-tween (PBS-tween). Plates were blocked 
with 1.0% bovine serum albumin (BSA) and incubated for two hours at room temperature. A 
standard was created using serum obtained from a convalescent patient diagnosed with 
typhoid. Volunteer samples were diluted four times across an optimised range for optimum 
comparison against the standard. Plates were washed, samples were added in duplicate and 
incubated at 4˚C overnight. For detection of IgG, plates were washed and incubated with 
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1:4,000 anti-human-IgG-alkaline-phosphatase (Sigma-Aldrich) for two hours. For detection 
of IgA, plates were washed and incubated with 1:4,000 anti-human-IgA (AbD Serotec) for 
two hours; plates were washed again and then incubated with 1:2,000 streptavidin:alkaline 
phosphotase (AbD Serotec) for one hour. For detection of both IgG and IgA, plates were 
washed and incubated with 100µL p-nitrophenyl phosphate (pNPP; Sigma-Aldrich). Optical 
density was measured at 405nm using a FLUOstar Omega ELISA plate reader (BMG 
Labtech). 
Statistical analyses  
Comparisons were made using paired and unpaired t tests, as indicated. Associations were 
measured using Pearson’s correlation coefficient. Statistical analyses were performed using 
Prism v5.03 (GraphPad). P values are two-tailed and considered significant at P<0.05. 
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FIGURE 1. Serum-specificity among IgG and IgA populations. The levels of IgG and 
IgA specific to S. Typhi LPS (A) and influenza (B) in serum expressed in arbitrary units 
(AU). For control (C; closed squares and circles) and vaccinated (V; open squares and 
circles) volunteers, paired comparisons were made between day 0 and day 18 values (paired t 
tests were performed using logarithmically transformed data).  
FIGURE 2. Representative flow cytometric gating strategy. Dot plots are shown for cells 
isolated from the duodenal mucosa (A) and peripheral blood (B). Dead cells, B cells and 
monocytes were removed by staining for viability (Vivid®), CD19 and CD14 and gating on 
the negative population. T-cells were identified according to the expression of CD3. T-cells 
were classified according to the expression of CD4 and CD8 and the expression of TNFα, 
IL2 and IFNγ cytokine assessed in non-stimulated (NS) and in Ty21a, influenza and SEB 
stimulated samples.  
FIGURE 3. Antigen-specific cytokine-producing populations at day 18. The frequency of 
CD4+ and CD8+ Ty21a-responsive and heterologous influenza-responsive populations 
expressing any combination of IFNγ ± TNFα ± IL2 above background. SEB-stimulated 
control data is also included. For control (C; closed squares, circles and triangles) and 
vaccinated (V; open squares, circles and triangles) volunteers, measurements were made at 
the duodenal mucosa (A), the colonic mucosa (B), and in peripheral blood (C). Horizontal 
bars represent mean values (comparisons were made using unpaired t tests). 
FIGURE 4. Combinations of antigen-specific cytokine production at day 18. The 
frequency of CD4+ and CD8+ Ty21a-responsive and heterologous influenza-responsive 
populations expressing one (+), two (++) or three (+++) cytokines (IFNγ ± TNFα ± IL2) 
above background. For control (C; closed squares, circles and triangles) and vaccinated (V; 
open squares, circles and triangles) volunteers, measurements were made at the duodenal 
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mucosa (A and B), and in peripheral blood (C and D). Horizontal bars represent mean values 
(comparisons were made using unpaired t tests). 
FIGURE 5. Integrin β7 expression intensity among T-cell populations at day 18. 
Geometric mean fluorescence intensity (MFI) expression of integrin β7 among non-stimulated 
total CD4+ and total CD8+ T-cell populations (control volunteers closed diamonds and 
vaccinated volunteers open diamonds), and in Ty21a-stimulated (control volunteers closed 
squares and vaccinated volunteers open squares) and heterologous-influenza-stimulated 
(control volunteers closed circles and vaccinated volunteers open circles) cytokine-producing 
subpopulations. Measurements were made at the duodenal mucosa (A), and in peripheral 
blood (B). Horizontal bars represent mean values (comparisons were made using unpaired t 
tests). 
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Table 1. Pearson correlation analysis of cellular and humoral immune responses. 
 
DUODENAL MUCOSA PERIPHERAL BLOOD SERUM 
Ty21a Influenza Ty21a Influenza S. Typhi LPS Influenza 
CD4+ CD8+ CD4+ CD8+ CD4+ CD8+ CD4+ CD8+ IgG IgA IgG IgA 
D
U
O
D
EN
A
L 
M
U
C
O
SA
 
Ty21a 
CD4+ 1 
0.537 
* 
0.741 
** 
0.724 
** 
0.530 
* 
0.319 
ns 
-0.102 
ns 
-0.223 
ns 
0.542 
* 
0.710 
* 
0.160 
ns 
0.008 
ns 
CD8+  1 
0.587 
** 
0.677 
** 
0.395 
ns 
0.126 
ns 
-0.117 
ns 
-0.232 
ns 
0.315 
ns 
0.396 
ns 
0.177 
ns 
-0.348 
ns 
Influenza 
CD4+   1 
0.929 
** 
0.327 
ns 
0.299 
ns 
-0.025 
ns 
-0.122 
ns 
0.392 
ns 
0.512 
* 
-0.245 
ns 
-0.228 
ns 
CD8+    1 
0.394 
ns 
0.515 
ns 
0.099 0.080 0.392 0.585 
** 
-0.149 
ns 
-0.300 
ns ns ns ns 
*P<0.05 (light grey); **P<0.001 (dark grey) 
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